4.7 Article

Estrogen receptor subtypes selectively mediate female mouse reproductive abnormalities induced by neonatal exposure to estrogenic chemicals

Journal

TOXICOLOGY
Volume 253, Issue 1-3, Pages 117-124

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.tox.2008.09.006

Keywords

Diarylpropionitrile; Diethylstilbestrol; Neonatal treatment; Mouse; Adverse effects

Funding

  1. Ministry of Education, Culture, Sport, Science and Technology (B)
  2. Ministry of Health Labor and Welfare, Japan

Ask authors/readers for more resources

Perinatal exposure to estrogens such as diethylstilbestrol (DES), and to estrogenic chemicals, induces persistent anovulation caused by a I teration of hypothalamic-pituitary-gonadal (HPG) axis, polyovular follicles, uterine abnormalities and persistent vaginal changes in mice, Most activities of estrogenic chemicals are mediated through estrogen receptora alpha (ER alpha) and/or ER beta. However, little was known about the relative contribution of the individual ER subtypes in induction of abnormalities. We tested the effects of neonatal exposure to ER selective ligands and DES on female mice. Transactivation assays using mouse ER alpha and ER beta showed that 10(-10) M DES activated both ER subtypes and that the ER alpha agonist (propyl pyrazole triol, PPT) and the ER beta agonist(diarylpropionitrile, DPN) selectively activated their respective ERs at 10(-9) M. Neonatal female mice were injected subcutaneously with DES, PPT or DPN and the animals were examined at 13 and 15 weeks of age, respectively. Persistent estrous smears and anovulation were induced in all mice by 0.025-2.5 mu g DES and 2.5-25 mu g PPT, but not by DPN, suggesting that the observed anovulation was primarily mediated through ER alpha. Disorganization Of Uterine Musculature and ovary-independent vaginal epithelial cell proliferation accompanied by persistent expression of EGF-related genes and interleukin-1-related genes were also mediated through ER alpha. In contrast, polyovular follicles were induced by neonatal treatment with both ER alpha and ER beta ligands, suggesting that ovarian abnormalities are mediated through both ER subtypes. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available